BioWorld - Saturday, December 13, 2025
See today's BioWorld
To read the full story, subscribe or sign in.

Nextcure stock continues wild way, drops on updated data

Nov. 12, 2019
By Lee Landenberger
Shares of Nextcure Inc. (NASDAQ:NXTC) have alternately been up sharply lately or down dramatically. Following the weekend release of updated positive clinical data from its NC-318 phase I/II study, the share price nosed down 52.9% Monday.
BioWorld Clinical